Last updated: May 4, 2026
Suppliers for the Pharmaceutical Drug “MANNITOL 20%”
What is “MANNITOL 20%” in pharmaceutical sourcing terms?
“MANNITOL 20%” is typically supplied as a sterile, injectable mannitol solution at 20% w/v (commonly 20 g/100 mL; strengths often expressed as 200 mg/mL). In procurement, suppliers usually differentiate by: container type (bottle vs. bag), pack size, sterility assurance, regulatory status (US/EU/UK), and supply format (finished drug product vs. bulk mannitol for formulation).
Because “MANNITOL 20%” is a broadly used excipient-turned-API product in hospitals, sourcing often includes both finished dosage form suppliers (ready-to-administer infusion) and manufacturer/distributor channels for hospitals and wholesalers.
Who supplies MANNITOL 20% finished injectable product (global channels)?
Below are active, commonly encountered supplier categories for mannitol 20% injectable solution, aligned to typical market availability.
| Supplier / Brand channel |
Typical role in supply chain |
Product format seen in market |
Notes for procurement |
| B. Braun |
Finished drug product supplier / hospital supply |
Mannitol injection (concentration commonly aligned to 15% to 20% depending on region) |
Common EU/UK/Global hospital channel presence |
| Fresenius Kabi |
Finished drug product supplier |
Mannitol injection (region-dependent strength and pack) |
Strong hospital distribution footprint |
| Hospira (Pfizer legacy) / Pfizer channels |
Finished drug product supplier |
Mannitol injection historically common in IV solutions portfolios |
Availability depends on country market history |
| Baxter |
Finished drug product supplier |
IV solutions including osmotic agents (region-dependent) |
Channel depends on local registration |
| Sandoz / Novartis generic channels |
Generic/manufacturer channel |
Mannitol injection |
Availability varies by registration and tender |
| Wuxi / Sinopharm / local large pharma distributors (China and APAC) |
Distributor-manufacturer channel |
Injectable mannitol solution |
Often supplies through national tenders and exports |
| Indian generic manufacturers (multiple) |
Finished product or contract manufacturing |
Mannitol injection 20% (tender-driven) |
Strength and pack sizes vary; verify local labeling |
Procurement reality: in most jurisdictions, you source through local tender lists or hospital wholesalers that carry region-specific registrations. For multinational buying, you usually end up with one of the above brand families plus local registered generics.
Who supplies mannitol 20% through hospital wholesaler/distributor networks?
In practice, the most reliable sourcing comes from registered wholesalers in the target geography. Supplier identities change by country, but the channel structure stays consistent:
- Hospital wholesalers (tender-managed drug supply)
- Licensed importers (for cross-border finished goods)
- Distributor aggregators (multi-manufacturer portfolios)
In many markets, wholesaler procurement is tied to:
- National Drug Codes / local product identifiers
- Lot-release and quality documentation
- Storage temperature and handling requirements
- Expiry and shelf-life minimums
What specs matter when selecting a supplier for MANNITOL 20%?
To avoid mis-supply, requests for quotation typically lock down these attributes:
| Specification category |
What to confirm |
| Strength |
Confirm 20% w/v and label equivalence to 200 mg/mL |
| Dosage form |
Sterile injectable solution intended for IV infusion/use |
| Container |
Glass vial vs. plastic bag (and stated pack size, e.g., 100 mL/250 mL) |
| Sterility and quality |
Sterility assurance level, batch release documents, CoA, and relevant pharmacopoeial compliance |
| Stability/handling |
Storage conditions, light protection (if specified), and shelf-life at receipt |
| Labeling |
Country-specific labeling, language, and required safety statements |
| Regulatory status |
Local registration/marketing authorization in destination country |
| Packaging and logistics |
Incoterms, palletization, case count, and shipment lead time |
What supplier types exist for MANNITOL 20% (and how they differ)?
| Supplier type |
Product scope |
Typical buyer |
Key constraint |
| Finished-dose product manufacturers |
Registered infusion product |
Hospitals, distributors, government tenders |
Must match local registration and presentation |
| Contract manufacturing organizations (CMOs) |
Can produce under client labels |
Brand owners, importers |
Requires packaging, labeling, and regulatory pathway clarity |
| API/bulk mannitol suppliers (not finished drug) |
Bulk mannitol substance |
Formulators (if compounding permitted) |
You need the full sterile formulation chain and approval to sell as injectable |
How to validate a supplier quickly in bid evaluation
Most procurement failures come from strength or container mismatches, not from mannitol identity itself. Fast bid screening usually checks:
- Exact concentration on labeling (20% w/v)
- Container configuration (vial vs. bag) and pack size
- Regulatory dossier / local authorization proof
- Batch CoA availability for recent manufacturing lots
- Sterility documentation and compliance statements
- Shelf-life minimum at delivery (often enforced by tenders)
Key Takeaways
- “MANNITOL 20%” is commonly sourced as a sterile IV injectable mannitol solution at 20% w/v (200 mg/mL); bid documents must lock strength and presentation.
- Supply typically comes from finished-dose manufacturers (e.g., large hospital-injection portfolios such as B. Braun and Fresenius Kabi) plus region-specific generic manufacturers.
- The fastest route in most countries is through registered wholesalers and tender portfolios, with strict checks on strength, container type, registration status, and batch documentation.
FAQs
1) Is mannitol 20% the same as 200 mg/mL?
Yes. 20% w/v corresponds to 200 mg/mL.
2) Do major manufacturers supply mannitol 20% in every country?
No. Strength, packaging, and availability depend on local registration and historical tender/portfolio decisions.
3) What is the most common reason suppliers are rejected for mannitol 20%?
Incorrect concentration or presentation (wrong vial/bag format or pack size).
4) Can bulk mannitol suppliers be used to procure mannitol 20% injectable?
Only if you have the approved capability to manufacture/sterile-formulate and sell a finished sterile injectable product under the correct regulatory pathway. Most buyers want a finished injectable.
5) What documents typically decide lot-release for mannitol 20%?
Recent CoA, sterility/quality documentation, batch traceability, and compliance statements aligned to the destination jurisdiction’s requirements.
References
[1] European Medicines Agency. Public assessment reports and product information for mannitol-containing IV solutions (search within EMA product pages). EMA. https://www.ema.europa.eu/
[2] U.S. FDA. Drug approvals and labeling resources for mannitol injection products (search by “mannitol injection 20%” and “mannitol injection”). FDA. https://www.fda.gov/
[3] B. Braun. Hospital products and infusion solutions catalog (mannitol injection entries vary by region). B. Braun. https://www.bbraun.com/
[4] Fresenius Kabi. Product portfolio for IV solutions and mannitol injection (availability varies by market). Fresenius Kabi. https://www.fresenius-kabi.com/
